DIEBOLD NIXDORF INC (DBD)
US2536512021 - Common Stock
We assign a fundamental rating of 4 out of 10 to DBD. DBD was compared to 32 industry peers in the Technology Hardware, Storage & Peripherals industry. There are concerns on the financial health of DBD while its profitability can be described as average. DBD has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
DBD had negative earnings in the past year.
In the past year DBD has reported a negative cash flow from operations.
In the past 5 years DBD reported 4 times negative net income.
In multiple years DBD reported negative operating cash flow during the last 5 years.
1.2 Ratios
With an excellent Return On Assets value of 33.06%, DBD belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Return On Equity of DBD (129.36%) is better than 96.88% of its industry peers.
With a decent Return On Invested Capital value of 4.36%, DBD is doing good in the industry, outperforming 65.63% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for DBD is significantly below the industry average of 14.47%.
The last Return On Invested Capital (4.36%) for DBD is above the 3 year average (4.34%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 33.06% | ||
| ROE | 129.36% | ||
| ROIC | 4.36% |
ROA(3y)3.95%
ROA(5y)-0.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.34%
ROIC(5y)4.03%
1.3 Margins
Looking at the Profit Margin, with a value of 36.59%, DBD belongs to the top of the industry, outperforming 96.88% of the companies in the same industry.
The Operating Margin of DBD (4.02%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of DBD has grown nicely.
DBD has a Gross Margin of 23.30%. This is in the lower half of the industry: DBD underperforms 65.63% of its industry peers.
In the last couple of years the Gross Margin of DBD has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.02% | ||
| PM (TTM) | 36.59% | ||
| GM | 23.3% |
OM growth 3Y7.99%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.9%
GM growth 5Y3.02%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DBD is destroying value.
DBD has less shares outstanding than it did 1 year ago.
DBD has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, DBD has an improved debt to assets ratio.
2.2 Solvency
DBD has an Altman-Z score of 1.48. This is a bad value and indicates that DBD is not financially healthy and even has some risk of bankruptcy.
DBD has a Altman-Z score of 1.48. This is comparable to the rest of the industry: DBD outperforms 43.75% of its industry peers.
DBD has a Debt/Equity ratio of 1.18. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.18, DBD is doing worse than 68.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.48 |
ROIC/WACC0.46
WACC9.4%
2.3 Liquidity
DBD has a Current Ratio of 1.52. This is a normal value and indicates that DBD is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DBD (1.52) is worse than 68.75% of its industry peers.
A Quick Ratio of 1.10 indicates that DBD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.10, DBD is doing worse than 65.63% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.52 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
DBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.21%, which is quite impressive.
DBD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.66%.
Measured over the past years, DBD shows a decrease in Revenue. The Revenue has been decreasing by -3.86% on average per year.
EPS 1Y (TTM)23.21%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q282.28%
Revenue 1Y (TTM)8.66%
Revenue growth 3Y-1.23%
Revenue growth 5Y-3.86%
Revenue growth Q2Q7.02%
3.2 Future
DBD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 260.92% yearly.
The Revenue is expected to grow by 2.32% on average over the next years.
EPS Next Y1039.53%
EPS Next 2Y260.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.38%
Revenue Next 2Y2.32%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
DBD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 8.15, the valuation of DBD can be described as very reasonable.
84.38% of the companies in the same industry are more expensive than DBD, based on the Price/Forward Earnings ratio.
DBD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.67.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 8.15 |
4.2 Price Multiples
78.13% of the companies in the same industry are more expensive than DBD, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.68 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DBD's earnings are expected to grow with 260.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y260.92%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for DBD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
DIEBOLD NIXDORF INC
NYSE:DBD (4/24/2024, 7:04:00 PM)
After market: 32.93 0 (0%)32.93
+0.41 (+1.26%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.24B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 8.15 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 33.06% | ||
| ROE | 129.36% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 4.02% | ||
| PM (TTM) | 36.59% | ||
| GM | 23.3% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.9
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.18 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.52 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)23.21%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y1039.53%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.66%
Revenue growth 3Y-1.23%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y